Advances in Cancer Immunotherapy™ (ACI) Series

ACI programs are certified for CME, CNE, CPE, and MOC credits. ACI's offer in-depth clinical training in immunotherapy treatment for a variety of disease states and topics. ACI webinars are FREE for healthcare professionals, students, patients and patient advocates.

Targets for Cancer IO: 2024 Deep Dive - A Deep Dive into Personalized Vaccines

Live Webinar 2 Starts Wednesday, May 22, 2024, from 12–2 p.m. EDT

Key leaders in the field who are experts in their respective fields will provide an overview of the current state of the science and address questions about its future.

Advances in Cancer Immunotherapy™: A Focus on Genitourinary Cancers

Tuesday, June 11 |11 a.m.–3 p.m. ET
Virtual – Zoom

Identify the cancer immunotherapy approaches in use for the treatment of genitourinary cancers. FREE for healthcare professionals, students, patients and patient advocates.

Advances in Cancer Immunotherapy™: A Focus on Lung Cancers

Tuesday, June 25 |1–5 p.m. ET
Virtual – Zoom

Program features a discussion on immunotherapy and biomarker-driven lung cancer. FREE for healthcare professionals, students, patients and patient advocates.

SITC Summit on Immunomodulation of Antibody-drug Conjugates

Wednesday, June 26, 2024 
11 A.M.–3 P.M.

The free summit will highlight the current understanding of antibody-drug conjugates (ADCs) and their effects on the immune system and the tumor microenvironment.

Nominate an Emerging Leader in IO

Submit Nominations by July 15

The Steven A. Rosenberg Scholars Award is one of the society's most prestigious opportunities for early career scientists. If you know a deserving emerging leader, nominate them by July 15, 2024.

Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies

Wednesday, Sept. 11 |1–5 p.m. ET 
Virtual – Zoom

Program addresses how to identify and manage CAR T -associated secondary malignancies. FREE for healthcare professionals, students, patients and patient advocates.

SITC Immuno-oncology Drug Development Summit

Sept. 30 – Oct. 1, 2024 in Boston at The Revere Hotel Boston Common

The SITC Immuno-oncology Drug Development Summit will ensure that active, innovative new therapies are rapidly and appropriately moved into clinical testing.

Advances in Cancer Immunotherapy™: A Focus on Intratumoral Therapies, Vaccines, & Cytokines

Wednesday, Oct. 9 |11 a.m.–3 p.m. ET Virtual – Zoom

Program features a session on emerging therapies, where the EMERALD trial and FLASH radiotherapy plan to be discussed.